PTPRC and cancer: Furthermore, we performed flow cytometry analysis in 4T1 BCBM tumors showing that P-TBK1 was highly expressed in CD45+CD11b+CD68+ TAMs, but not in CD45− cancer cells (SI Appendix, Fig. S1 B and C).